Abstract
Liver cell therapy presents a promising alternative to liver transplantation for patients with liver failure and hereditary liver diseases. However, its clinical implementation is limited largely due to the scarcity of human hepatocytes. Here, we review strategies to generate functional human hepatocytes with a mature phenotype and liver repopulation capability and highlight their potential clinical applications in hepatocyte transplantation and bioartificial liver transplantation. We summarize new delivery methods to improve hepatocyte engraftment, such as patch grafting and ectopic transplantation, and discuss potential future directions.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
